STAT3 and non-small cell lung carcinoma: We also found the inhibition of phospho-STAT3 and PD-L1 expression in NSCLC cells by nobiletin treatment, suggesting the possible role of miR-197 in the inhibition of STAT3 and PD-L1 by nobiletin.